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ABSTRACT
STK15 is a serine/threonine kinase that regulates chromosomal segregation during mitosis. Single nucleotide polymorphisms 
(SNPs) in this gene, Phe31Ile (rs2273535) and Val57Ile (rs1047972), are inconsistently associated with gastrointestinal 
cancer (GIC) across different populations. However, this association is unclear in Malaysian population. Therefore, this 
study investigated the association of STK15 Phe31Ile and Val57Ile polymorphisms to GIC risk in Malaysia. Genomic DNA 
was extracted from 185 GIC patients and 1110 healthy controls and was subjected to polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) analysis. SNPs were further confirmed using sequencing. We found that the 
31Phe allele and 31Phe/Phe genotype in the Phe31Ile SNP significantly increased GIC risk in Malaysian population, 
particularly in gastric cancer (p<0.017). The combined analysis for both SNPs also increased the risk of GIC in this 
study. Etiological factors such as age, gender and ethnicity were not associated with GIC in the population. This is the 
first study to report the association of STK15 Phe31Ile and Val57Ile SNPs with an increased risk of GIC in Malaysians; 
the 31Phe allele is exclusively associated with the risk of gastric cancer. In addition, GIC incidences among Malaysians 
have significantly shifted to a younger age (<50 years).
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ABSTRAK
STK15 adalah kinase serin/treonina yang mengawal perpisahan kromosom semasa mitosis. Polimorfisme nukleotida 
tunggal (SNPs) pada gen ini, Phe31Ile (rs2273535) dan Val57Ile (rs1047972) adalah dikaitkan dengan kanser 
gastrousus (GIC) secara tidak tekal dalam populasi yang berbeza. Walau bagaimanapun, perkaitan tersebut adalah 
tidak jelas di dalam populasi di Malaysia. Oleh itu, penyelidikan ini mengkaji perkaitan bagi polimorfisme STK15 
Phe31Ile dan Val57Ile terhadap risiko GIC di Malaysia. DNA genom diekstrak daripada 185 pesakit GIC dan 1110 
kawalan yang sihat. Seterusnya, analisis tindak balas berantai polimerase pemotongan panjang cebisan (PCR-RFLP) 
dijalankan dan SNP turut disahkan dengan menggunakan teknik penjujukan DNA. Kami mendapati bahawa alel 31Phe 
dan genotip 31Phe/Phe dalam SNP Phe31Ile meningkatkan risiko terhadap GIC dalam populasi di Malaysia secara 
signifikan, terutamanya dalam kanser gastrik (p<0.017). Analisis gabungan bagi kedua-dua SNP juga meningkatkan 
risiko terhadap GIC dalam kajian ini. Faktor etiologi seperti umur, jantina dan etnik adalah tidak berkait dengan 
GIC dalam populasi ini. Kajian ini merupakan kajian pertama yang melaporkan tentang perkaitan antara SNP STK15 
Phe31Ile dan Val57Ile dengan peningkatan risiko terhadap GIC di Malaysia; terutamanya alel 31Phe yang dikaitkan 
dengan risiko kanser gastrik. Selain itu, kejadian GIC dalam kalangan rakyat Malaysia telah beralih secara signifikan 
kepada usia yang lebih muda (<50 tahun).
Kata kunci: Kanser gastrousus; polimorfisme STK15; populasi Malaysia
INTRODUCTION
STK15 is a serine/threonine kinase involved in mitotic 
entry, separation of centriole pairs, accurate bipolar 
spindle assembly, and chromosome alignment during the 
metaphase in a cell (Dutertre et al. 2002). STK15 maps to 
chromosome 20q13.2, a common site of amplification 
in tumours. It has been shown to have a low penetrance 
cancer susceptibility gene that affects multiple cancer types 
(Ewart-Toland et al. 2005). Over-expression of this gene 
is oncogenic because it causes centrosome amplification, 
chromosome instability, transformation in vitro and 
tumorigenesis in mammalian cell lines (Bischoff et al. 
1998; Sakakura et al. 2001). A recent study also reported a 
significant up-regulation of STK15 in esophageal squamous 
cell carcinoma tumors when compared to normal tissues 
(Chen et al. 2014).
 There are two polymorphic sites of STK15, namely, 
the Phe31Ile (rs2273535) and Val57Ile (rs1047972) that 
are reported to affect the pathogenesis of cancer. These 
two single nucleotide polymorphisms (SNPs) are in the 
conserved region of the NH2-terminal region that is 
involved in ubiquitin-based proteolysis (Honda et al. 2000). 
Amino acid 31Phe binds with the E2 ubiquitin conjugating 
enzyme UBE2N during mitosis at the centrosome. Loss of 
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UBE2N binding function with the STK15 variant has been 
reported to increase susceptibility to human cancer (Ewart-
Toland et al. 2003). The function of Val57Ile SNP has not 
been identified. However, it might be important for kinases 
activity as the 57Ile homozygote genotype has 57.5% less 
kinases activity and showed more chromosome instability 
than the 57Val homozygote genotype (Dogan et al. 2008).
These two SNPs are associated independently with 
both sporadic and hereditary cancers, especially in 
gastrointestinal cancer (GIC) including esophageal, gastric, 
pancreas, and colorectal as well as other cancers such as 
breast, ovarian and lung through case-control or meta-
analysis studies in different populations (Chen et al. 2014, 
2007; Chong et al. 2016; Dai et al. 2014; Ju et al. 2006; 
Kimura et al. 2005; Qin et al. 2015; Tang et al. 2013; Xu 
et al. 2014). We have previously reported that carriers with 
at least one copy of the c2 allele in the CYP2E1 gene was 
associated to GIC in Malaysians (Chong et al. 2014), but the 
association of the Phe31Ile and Val57Ile SNPs in STK15 to 
GIC in the population is still unclear. Furthermore, previous 
studies of these SNPs in different populations showed 
contradicting outcomes and inconsistent associations. 
Therefore, we conducted this study to screen the frequency 
of these STK15 SNPs and to determine the association with 
the risk of getting GIC in Malaysian GIC patients.
MATERIALS AND METHODS
SUBJECTS AND SAMPLE COLLECTION
A total of 185 GIC patients (gastric = 41, colorectal = 
126, esophageal = 4, pancreas = 7, liver = 3 and anus = 
4) who were admitted to Queen Elizabeth Hospital, Kota 
Kinabalu, Sabah and University Malaya Medical Centre, 
Kuala Lumpur and 1110 healthy volunteers randomly 
selected during blood donation campaigns were recruited 
from 2010 to 2014. This study conforms to The Code of 
Ethics of the World Medical Association (Declaration 
of Helsinki) and written consent was obtained from all 
subjects. Five mL of peripheral blood was obtained in BD 
Vacutainer® containing EDTA (Becton Dickinson, New 
Jersey, USA), and data including age, gender and ethnicity 
were collected from all subjects. Clinical characteristics 
for GIC and lifestyles of the subjects were not available 
as data collection was limited; this study solely focused 
on the association of the STK15 gene polymorphisms to 
GIC. Overall, 68.03% of the study population were male, 
while 31.97% were female with age ranging from 15 to 93 
years (mean age ± S.D. = 31.93 ± 14.83) and comprised of 
Malaysian Chinese (22.08%), Malay (9.03%), Malaysian 
Indian (3.71%), Kadazan-Dusun (24.40%), Bajau (9.34%) 
and other ethnicities (31.44%) that are indigenous in East 
Malaysia. This study was approved by Sabah State Health 
Department and Queen Elizabeth Hospital, Kota Kinabalu 
and the ethical approval was obtained from the University 
Malaya Medical Centre (UMMC) Ethical Board with Ref. 
654.1.
STK15 GENOTYPING AND DIRECT SEQUENCING
Genomic DNA was extracted using an alkaline 
phenol-chloroform lysis method from whole blood, 
and genotyping was carried out using a polymerase 
chain reaction followed by restriction fragment length 
polymorphism (PCR-RFLP) analysis. Primers used 
were 5’-CTTTCATGAATGCCAGAAAGTT-3’/5’-
CTGGGAAGAATTTGAAGGACA-3’ for Phe31Ile 
SNP and 5’-CTTTCATGAATGCCAGAAAGTT-3’/5’-
CTGCTTCTGATTCTGAACCGGCTTG-3’ for Val57Ile 
SNP studies, respectively. The PCR reaction was carried out 
in a 25 μL volume containing 100 ng of extracted DNA, 
0.2 μM of each primer, 0.2 mM of each dNTPs, 1.5 mM 
of MgCl2 and 1 unit of HotStarTaq® DNA polymerase 
(Qiagen, Germany). The reaction was performed with 
the following conditions: 1 cycle for 15 min at 95°C; 35 
cycles for 30 s at 94°C, 30 s at 55°C and 30 s at 72°C; and 
a final elongation step for 7 min at 72°C for both primer 
sets. The PCR product was digested with 5 units of ApoI 
(NEB Inc., Ipswich, MA) at 50°C overnight for Phe31Ile 
polymorphism and 5 units of BstUI (NEB Inc., Ipswich, 
MA) at 60°C overnight for Val57Ile polymorphism. The 
resulting fragments were analyzed with 3% agarose gel 
electrophoresis. PCR products for both polymorphisms 
were sequenced using the ABI PRISM 3100 Genetic Analyzer 
(Applied Biosystems, USA) for confirmation.
STATISTICAL ANALYSIS
The Hardy-Weinberg equilibrium (HWE) was tested for 
genotype distribution in controls and cases for both 
polymorphisms, which were represented by χ2 value 
(within HWE if χ2 < 3.84, df = 1). By taking the 31Ile and 
31Ile/Ile for Phe31Ile and 57Val and 57Val/Val for Val57Ile 
SNPs as reference, SPSS Software V17.0 (SPSS Inc, Chicago, 
Illinois, USA) was used to estimate the allelic and genotypic 
interactions in GIC development by calculating the odd’s 
ratio (OR) and 95% confidence interval (95% CI). The 
interactions were statistically significant when the p-value 
was less than 0.05 using the Fisher’s exact test. For the 
sub-group analysis, the association test was considered 
statistically significant only after Bonferroni correction.
RESULTS
Genotype distributions were tested for Phe31Ile (cases, 
χ2 = 0.30; controls, χ2 = 1.22) and Val57Ile (cases, χ2 = < 
0.01; controls, χ2 = 0.55) SNPs and they were within the 
HWE. The heterozygousity and homozygousity for both 
SNPs were sequenced and matched with the PCR-RFLP 
analysis data. For the Phe31Ile SNP, the 31Ile and 31Phe 
allele frequencies among all the subjects were 59.19% and 
40.81%, respectively. The genotype frequency was 34.29% 
for 31Ile/Ile, 49.81% for 31Phe/Ile and 15.90% for 31Phe/
Phe (Table 1). The 31Phe allele and 31Phe/Phe genotype 
showed a strong significant association with an increased 
risk of GIC, especially in gastric cancer with Bonferroni 
correction (Table 2).
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 In the Val57Ile SNP analysis, 83.98% of allele 
frequency was the 57Val, while for 57Ile, it was 16.02% 
in this study. The genotype distributions for 57Val/Val, 
57Val/Ile and 57Ile/Ile were 70.27%, 27.41%, and 2.32%, 
respectively. There was no significant evidence for this 
SNP to increase the risk of GIC, but the combined analysis 
of the Phe31Ile and Val57Ile SNPs showed that the 31Phe 
+ 57Ile alleles as well as the 31Phe/Phe + 57Val/Ile and 
31Phe/Phe + 57Ile/Ile genotypes increased the risk to GIC 
significantly in the Malaysian population. Etiological 
factors including age, gender and ethnicity were not 
associated with GIC for both SNPs in this study (Tables 3 
and 4).
DISCUSSION
To the best of our knowledge, this is the first study to 
report a significant risk association of the STK15 Phe31Ile 
and Val57Ile SNPs with GIC in the Malaysian population by 
including indigenous ethnics in East Malaysia. By using 
MuPro software (Cheng et al. 2006), the presence of the 
Phe31Ile SNP in the STK15 gene has been predicted to 
decrease the stability of the protein structure (confidence 
score = -0.577) whereas the Val57Ile SNP appears to 
increase the stability of the gene (confidence score = 
0.038). The conflicting predictions of both SNPs towards 
the stability of the protein structure making them worth 
to be studied, especially their associations to the risk of 
GIC that encounter approximately 2.9 million of deaths 
globally in 2012 (IARC 2014) and mortality rate of 4.71 
per 0.1 million of populations in Malaysia (Department 
of Health Statistics Malaysia 2013) and the mortality rate 
for GIC is projected to increase continuously in the future. 
In this study, we mainly focused on gastric and colorectal 
cancers due to our sample limitation.
 A previous study reported that the 31Ile allele in 
Phe31Ile SNP was more common in Asian (Ewart-Toland 
et al. 2005) and therefore we took it as the reference 
allele in this study. We found that the 31Phe allele and 
the 31Phe/Phe genotype elevated the risk of GIC in our 
Malaysian sample, mainly in gastric cancer even after the 
Bonferroni correction; suggesting that the 31Phe allele is 
highly associated with increased risk of GIC and may act 
as a biomarker for early detection of gastric cancer in the 
Malaysian population. Although the presence of 31Phe 
was not associated with esophageal cancer in this study, 
contradicting results were previously reported where 
Kimura et al. (2005) claimed that 31Phe/Phe genotype 
TABLE 1. Risk association of STK15 Phe31Ile and Val57Ile polymorphisms to GIC in Malaysians
Cases, N Controls, N OR (95% CI) p-value
Phe31Ile SNP
 Allele
  31 Ile
  31 Phe
 Genotype
  31 Ile/Ile
  31 Phe/Ile
  31 Phe/Phe
  31 Phe/Ile + 31 Phe/Phe
194
176
49
96
40
136
1339
881
395
549
166
715
1.00 (Reference)
1.38 (1.11 – 1.72)
1.00 (Reference)
1.41 (0.98 – 2.04)
1.94 (1.23 – 3.06)
1.53 (1.08 – 2.17)
-
0.005*
-
0.070
0.005*
0.015*
Val57Ile SNP
 Allele
  57 Val
  57 Ile
 Genotype
  57 Val/Val
  57 Val/Ile
  57 Ile/Ile
  57 Val/Ile + 57 Ile/Ile
303
67
124
55
6
61
1872
348
786
300
24
324
1.00 (Reference)
1.19 (0.89 – 1.59)
1.00 (Reference)
1.16 (0.82 – 1.64)
1.59 (0.64 – 3.95)
1.19 (0.86 – 1.66)
-
0.251
-
0.419
0.289
0.298
Phe31Ile + Val57Ile SNPs
 Allele
  31 Ile + 57 Val
  31 Phe + 57 Ile
 Genotype
  31 Ile/Ile + 57 Val/Val
  31 Phe/Ile + 57 Val/Ile
  31 Phe/Ile + 57 Ile/Ile
  31 Phe/Phe + 57 Val/Ile
  31 Phe/Phe + 57 Ile/Ile
497
243
173
151
102
95
46
3211
1229
1181
849
573
466
190
1.00 (Reference)
1.28 (1.08 – 1.51)
1.00 (Reference)
1.21 (0.96 – 1.54)
1.22 (0.93 – 1.58)
1.39 (1.06 – 1.83)
1.65 (1.15 – 2.37)
-
0.005*
-
0.116
0.149
0.020*
0.008*
*, statistical significant (p < 0.05)
SNP = single nucleotide polymorphism, N = number of samples, OR = odd ratio, CI = confidence interval, Ile = isoleucine, Phe = 
phenylalanine, Val = valine
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increased the risk of esophageal cancer (OR = 1.93, 95% 
CI = 0.90-4.16) but Miao et al. (2004) showed that 31Ile/
Ile genotype was significantly associated with increased 
risk of esophageal cancer (OR = 1.97, 95% CI = 1.36-2.85). 
Interestingly, Pan et al. (2012) reported that 31Phe/Ile 
genotype was significantly associated with recurrence of 
esophageal cancer with OR = 4.39 (95% CI = 2.12-8.94). 
Therefore, SNP association studies targeting specific type of 
GIC cancers are needed in the future for more precise risk 
estimation and healthcare approaches given to each cancer 
should be distinguished empirically in the Malaysian 
population.
 We had no evidence to associate the variant allele 
and genotype in Val57Ile SNP alone to an increase in the 
risk of GIC, but past studies showed that the 57Ile/Ile 
genotype was protective against lung cancer in Caucasians 
(OR = 0.72, 95% CI = 0.41-1.26) and breast cancer in Han 
Chinese (OR = 0.8, 95% CI = 0.4-1.6) (Dai et al. 2004; 
Gu et al. 2007), indicating that the Val57Ile SNP affects 
different cancer development across different populations. 
However, combined analysis of both SNPs in this study 
showed an increase risk to GIC significantly. Since STK15 
is a low penetrance gene, it is discrepant to claim that the 
gene alone is the significant genetic factor to GIC regardless 
of the influence of the environmental factors. Therefore, 
additional work on gene-environmental interactions to GIC 
development should be conducted for validation.
 In this study, age and STK15 polymorphisms were not 
interacting factors that contributed to GIC, but we noticed 
that around 26.49% of GIC patients in our database were 
less than 50 years old. This statistic was much higher 
than those previously reported by the Malaysian Gastro-
Intestinal Registry (MGIR) with only 18.14% (MGIR 2009); 
this suggests that GIC cases are becoming common among 
younger individuals and therefore screening for GIC should 
be performed before 50 years old among Malaysians to 
obtain better survival rates from GIC.
 Previously, we have reported that females had a nearly 
two-fold higher risk to GIC in the Malaysian population, but 
we did not analyze the association of different genotypes to 
TABLE 2. Risk association of STK15 Phe31Ile and Val57Ile polymorphisms to 
different types of GIC in Malaysians
Cases, N Controls, N OR (95% CI) p-value
Phe31Ile SNP
 Gastric
  31 Ile/Ile
  31 Phe/Ile
  31 Phe/Phe
  31 Phe/Ile + 31 Phe/Phe
 Colorectal
  31 Ile/Ile
  31 Phe/Ile
  31 Phe/Phe
  31 Phe/Ile + 31 Phe/Phe
 Others**
  31 Ile/Ile
  31 Phe/Ile
  31 Phe/Phe
  31 Phe/Ile + 31 Phe/Phe
6
18
17
35
40
69
17
86
3
9
6
15
395
549
166
715
395
549
166
715
395
549
166
715
1.00 (Reference)
2.16 (0.85 – 5.49)
6.74 (2.61 – 17.40)
3.22 (1.34 – 7.73)
1.00 (Reference)
1.24 (0.82 – 1.87)
1.01 (0.56 – 1.83)
1.19 (0.80 – 1.76)
1.00 (Reference)
2.16 (0.58 – 8.02)
4.76 (1.18 – 19.25)
2.76 (0.79 – 9.60)
-
0.106
<0.001*
0.009*
-
0.302
0.971
0.393
-
0.251
0.029
0.110
Val57Ile SNP
 Gastric
  57 Val/Val
  57 Val/Ile
  57 Ile/Ile
  57 Val/Ile + 57 Ile/Ile
 Colorectal
  57 Val/Val
  57 Val/Ile
  57 Ile/Ile
  57 Val/Ile + 57 Ile/Ile
 Others**
  57 Val/Val
  57 Val/Ile
  57 Ile/Ile
  57 Val/Ile + 57 Ile/Ile
25
15
1
16
89
32
5
37
10
8
0
8
786
300
24
324
786
300
24
324
786
300
24
324
1.00 (Reference)
1.57 (0.82 – 3.02)
1.31 (0.17 – 10.07)
1.55 (0.82 – 2.95)
1.00 (Reference)
0.94 (0.62 – 1.44)
1.84 (0.68 – 4.94)
1.01 (0.67 – 1.52)
1.00 (Reference)
2.10 (0.82 – 5.36)
-
1.94 (0.76 – 4.96)
-
0.175
0.795
0.178
-
0.783
0.227
0.967
-
0.123
-
0.166
*, statistical significant with Bonferroni correction (p < 0.017); **, including esophageal (N = 4), pancreas (N = 7), liver (N = 3), and anus (N = 4)
SNP = single nucleotide polymorphism, N = number of samples, OR = odd ratio, CI = confidence interval, Ile = isoleucine, Phe = phenylalanine, 
Val = valine
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TABLE 3. Association of age, gender and ethnicity in STK15 Phe31Ile SNP to GIC
Cases, N Controls, N OR (95% CI) p-value
Age
 < 50 years
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 ≥ 50 years
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
Gender
 Male
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Female
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
Ethnicity
 Chinese
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Malay
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Indian
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Kadazan-Dusun
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Bajau
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
 Others
  Ile/Ile
  Phe/Ile
  Phe/Phe
  Phe/Ile + Phe/Phe
14
23
12
35
35
73
28
101
23
50
17
67
26
46
23
69
18
33
12
45
2
5
0
5
0
2
0
2
14
27
14
41
6
10
6
16
9
19
8
27
379
531
160
691
16
18
6
24
295
383
113
496
100
166
53
219
97
100
26
126
38
50
22
72
5
21
20
41
95
133
33
166
41
46
12
58
119
199
53
252
1.00 (Reference)
1.17 (0.60 – 2.31)
2.03 (0.92 – 4.49)
1.37 (0.73 – 2.58)
1.00 (Reference)
1.85 (0.85 – 4.06)
2.13 (0.74 – 6.17)
1.92 (0.92 – 4.03)
1.00 (Reference)
1.67 (1.00 – 2.81)
1.93 (0.99 – 3.75)
1.73 (1.06 – 2.84)
1.00 (Reference)
1.07 (0.62 – 1.83)
1.67 (0.87 – 3.21)
1.21 (0.73 – 2.02)
1.00 (Reference)
1.78 ( 0.94 – 3.37)
2.49 (1.06 – 5.81)
1.93 (1.05 – 3.53)
1.00 (Reference)
1.90 (0.35 – 10.33)
-
1.32 (0.24 – 7.12)
1.00 (Reference)
-
-
-
1.00 (Reference)
1.38 (0.69 – 2.77)
2.88 (1.24 – 6.67)
1.68 (0.87 – 3.23)
1.00 (Reference)
1.49 (0.50 – 4.45)
3.42 (0.93 – 12.56)
1.89 (0.68 – 5.23)
1.00 (Reference)
1.26 (0.55 – 2.88)
2.00 (0.73 – 5.46)
1.42 (0.65 – 3.11)
-
0.645
0.080
0.328
-
0.123
0.162
0.083
-
0.061
0.066
0.028
-
0.891
0.131
0.526
-
0.084
0.057
0.041
-
0.695
-
1.000
-
-
-
-
-
0.393
0.021
0.160
-
0.589
0.077
0.239
-
0.685
0.183
0.455
N = number of samples, OR = odd ratio, CI = confidence interval, Ile = isoleucine, Phe = phenylalanine
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TABLE 4. Association of age, gender, and ethnicity in STK15 Val57Ile SNP to GIC
Cases, N Controls, N OR (95% CI) p-value
Age
 < 50 years
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 ≥ 50 years
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
Gender
 Male
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Female
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
Ethnicity
 Chinese
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Malay
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Indian
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Kadazan-Dusun
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Bajau
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
 Others
  Val/Val
  Val/Ile
  Ile/Ile
  Val/Ile + Ile/Ile
31
15
3
18
93
40
3
43
63
25
2
27
61
30
4
34
45
16
2
18
6
1
0
1
2
0
0
0
30
23
2
25
15
6
1
7
26
9
1
10
753
293
24
317
33
7
0
7
574
202
15
217
212
98
9
107
186
34
3
37
85
25
0
25
35
11
0
11
166
87
8
95
72
23
4
27
186
34
3
37
1.00 (Reference)
1.24 (0.66 – 2.34)
3.04 (0.87 – 10.63)
1.38 (0.76 – 2.50)
1.00 (Reference)
2.03 (0.83 – 4.97)
-
2.18 (0.89 – 5.32)
1.00 (Reference)
1.13 (0.69 – 1.84)
1.22 (0.27 – 5.43)
1.13 (0.70 – 1.83)
1.00 (Reference)
1.06 (0.65 – 1.75)
1.55 (0.46 – 5.19)
1.10 (0.68 – 1.78)
1.00 (Reference)
1.95 (0.99 – 3.83)
2.76 (0.45 – 16.98)
2.01 (1.05 – 3.85)
1.00 (Reference)
0.57 (0.07 – 4.93)
-
0.57 (0.07 – 4.93)
1.00 (Reference)
-
-
-
1.00 (Reference)
1.46 (0.80 – 2.67)
1.38 (0.28 – 6.84)
1.46 (0.81 – 2.62)
1.00 (Reference)
1.25 (0.44 – 3.60)
1.20 (0.13 – 11.51)
1.24 (0.46 – 3.38)
1.00 (Reference)
1.89 (0.82 – 4.39)
2.39 (0.24 – 23.79)
1.93 (0.86 – 4.35)
-
0.498
0.082
0.290
-
0.122
-
0.087
-
0.612
0.682
0.620
-
0.800
0.501
0.712
-
0.060
0.260
0.045
-
1.000
-
1.000
-
-
-
-
-
0.270
0.656
0.224
-
0.781
1.000
0.794
-
0.146
0.416
0.159
N = number of samples, OR = odd ratio, CI = confidence interval, Ile = isoleucine, Val = valine
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risk of GIC in both genders (Chong et al. 2014). We included 
the genotype analysis of the Phe31Ile and Val57Ile SNPs 
for both genders in this study and found no significant 
association of gender in both SNPs with GIC risk. Besides, 
Malaysia is a multi-ethnic country including a majority 
of Malay, Chinese and Indians in West Malaysia and 
indigenous ethnics such as Kadazan-Dusun and Bajau in 
East Malaysia and SNP association to GIC might be different 
across ethnicities. We observed no significant association 
of different ethnicities in both SNPs towards risk of GIC. 
Taken together, our study showed that etiological factors 
including age, gender, and ethnicity are not the risk factors 
for GIC in the Malaysian population.
CONCLUSION
We hereby conclude that the 31Ile allele and the 31Ile/Ile 
genotype in the STK15 Phe31Ile SNP significantly elevated 
the risk to GIC, particularly in gastric cancer. Despite that 
age and STK15 SNPs were not interacting factors associated 
with GIC, we recommend that screening for GIC should 
be done before 50 years old as GIC incidences have 
been alarmingly shifted to younger populations among 
Malaysians. As etiological factors such as age, gender 
and ethnicity are not risk factors for GIC in the Malaysian 
population, gene-gene and gene-environmental interactions 
should be taken into the account in future study with larger 
sample sizes for better risk estimation.
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